P22303 ACES_HUMAN
Gene name: ACHE
Protein name: Acetylcholinesterase
List of molecules and drugs that target protein P22303
# | DrugDomain Data | DrugBank Accession | Name | Drug action | Affinity data | InChI Key | SMILES |
---|---|---|---|---|---|---|---|
1 | P22303_DB00122 | DB00122 | Choline | product of | IC50(nM) = 3013006.02 | OEYIOHPDSNJKLS-UHFFFAOYSA-N | C[N+](C)(C)CCO |
2 | P22303_DB00382 | DB00382 | Tacrine | inhibitor | Ki(nM) = 6.9 IC50(nM) = 3.16 | YLJREFDVOIBQDA-UHFFFAOYSA-N | NC1=C2CCCCC2=NC2=CC=CC=C12 |
3 | P22303_DB00449 | DB00449 | Dipivefrin | inhibitor | OCUJLLGVOUDECM-UHFFFAOYSA-N | CNCC(O)C1=CC(OC(=O)C(C)(C)C)=C(OC(=O)C(C)(C)C)C=C1 | |
4 | P22303_DB00483 | DB00483 | Gallamine triethiodide | inhibitor | Ki(nM) = 37000.0 IC50(nM) = 2110000.0 | REEUVFCVXKWOFE-UHFFFAOYSA-K | [I-].[I-].[I-].CC[N+](CC)(CC)CCOC1=CC=CC(OCC[N+](CC)(CC)CC)=C1OCC[N+](CC)(CC)CC |
5 | P22303_DB00545 | DB00545 | Pyridostigmine | inhibitor | IC50(nM) = 350.0 | RVOLLAQWKVFTGE-UHFFFAOYSA-N | CN(C)C(=O)OC1=C[N+](C)=CC=C1 |
6 | P22303_DB00674 | DB00674 | Galantamine | inhibitor | Ki(nM) = 62.0 IC50(nM) = 100.0 EC50(nM) = 1100.0 | ASUTZQLVASHGKV-JDFRZJQESA-N | [H][C@]12C[C@@H](O)C=C[C@]11CCN(C)CC3=C1C(O2)=C(OC)C=C3 |
7 | P22303_DB00677 | DB00677 | Isoflurophate | inhibitor | Ki(nM) = 6000.0 IC50(nM) = 120.0 Kd(nM) = 13000.0 kon(M-1-s-1) = 2170.0 | MUCZHBLJLSDCSD-UHFFFAOYSA-N | CC(C)OP(F)(=O)OC(C)C |
8 | P22303_DB00733 | DB00733 | Pralidoxime | activator | Ki(nM) = 180000.0 IC50(nM) = 878000.0 | JBKPUQTUERUYQE-UHFFFAOYSA-O | C[N+]1=C(\C=N\O)C=CC=C1 |
9 | P22303_DB00805 | DB00805 | Minaprine | inhibitor | IC50(nM) = 85000.0 | LDMWSLGGVTVJPG-UHFFFAOYSA-N | CC1=CC(=NN=C1NCCN1CCOCC1)C1=CC=CC=C1 |
10 | P22303_DB00843 | DB00843 | Donepezil | inhibitor | Ki(nM) = 2.9 IC50(nM) = 2.0 Kd(nM) = 8.0 EC50(nM) = 43.0 | ADEBPBSSDYVVLD-UHFFFAOYSA-N | COC1=C(OC)C=C2C(=O)C(CC3CCN(CC4=CC=CC=C4)CC3)CC2=C1 |
11 | P22303_DB00863 | DB00863 | Ranitidine | inhibitor | VMXUWOKSQNHOCA-UHFFFAOYSA-N | CNC(NCCSCC1=CC=C(CN(C)C)O1)=C[N+]([O-])=O | |
12 | P22303_DB00898 | DB00898 | Ethanol | activator | LFQSCWFLJHTTHZ-UHFFFAOYSA-N | CCO | |
13 | P22303_DB00944 | DB00944 | Demecarium | inhibitor | RWZVPVOZTJJMNU-UHFFFAOYSA-N | CN(CCCCCCCCCCN(C)C(=O)OC1=CC=CC(=C1)[N+](C)(C)C)C(=O)OC1=CC=CC(=C1)[N+](C)(C)C | |
14 | P22303_DB00981 | DB00981 | Physostigmine | inhibitor | IC50(nM) = 0.43 | PIJVFDBKTWXHHD-HIFRSBDPSA-N | [H][C@]12N(C)CC[C@@]1(C)C1=C(C=CC(OC(=O)NC)=C1)N2C |
15 | P22303_DB00989 | DB00989 | Rivastigmine | inhibitor | Ki(nM) = 700.0 IC50(nM) = 37.0 kon(M-1-s-1) = 55.0 | XSVMFMHYUFZWBK-NSHDSACASA-N | CCN(C)C(=O)OC1=CC=CC(=C1)[C@H](C)N(C)C |
16 | P22303_DB01010 | DB01010 | Edrophonium | inhibitor | Ki(nM) = 1.6 IC50(nM) = 200.0 | VWLHWLSRQJQWRG-UHFFFAOYSA-O | CC[N+](C)(C)C1=CC(O)=CC=C1 |
17 | P22303_DB01122 | DB01122 | Ambenonium | inhibitor | Ki(nM) = 0.12 IC50(nM) = 0.7 | OMHBPUNFVFNHJK-UHFFFAOYSA-P | CC[N+](CC)(CCNC(=O)C(=O)NCC[N+](CC)(CC)CC1=CC=CC=C1Cl)CC1=CC=CC=C1Cl |
18 | P22303_DB01199 | DB01199 | Tubocurarine | inhibitor | JFJZZMVDLULRGK-URLMMPGGSA-O | [H][C@@]12CC3=CC=C(OC4=C5C(CC[N+](C)(C)[C@]5([H])CC5=CC(OC6=C(OC)C=C(CCN1C)C2=C6)=C(O)C=C5)=CC(OC)=C4O)C=C3 | |
19 | P22303_DB01245 | DB01245 | Decamethonium | inhibitor | Ki(nM) = 6000000.0 IC50(nM) = 1000.0 | MTCUAOILFDZKCO-UHFFFAOYSA-N | C[N+](C)(C)CCCCCCCCCC[N+](C)(C)C |
20 | P22303_DB01400 | DB01400 | Neostigmine | inhibitor | Ki(nM) = 23000.0 IC50(nM) = 0.043 | ALWKGYPQUAPLQC-UHFFFAOYSA-N | CN(C)C(=O)OC1=CC(=CC=C1)[N+](C)(C)C |
21 | P22303_DB01805 | DB01805 | Monoisopropylphosphorylserine | n/a | DALHHSOTZKMXMV-YFKPBYRVSA-N | [H][C@](N)(COP(O)(=O)OC(C)C)C(O)=O | |
22 | P22303_DB02166 | DB02166 | Propidium | n/a | ZDWVWKDAWBGPDN-UHFFFAOYSA-O | CC[N+](C)(CC)CCC[N+]1=C(C2=CC=CC=C2)C2=C(C=CC(N)=C2)C2=C1C=C(N)C=C2 | |
23 | P22303_DB02226 | DB02226 | 3,8-Diamino-6-Phenyl-5-[6-[1-[2-[(1,2,3,4-Tetrahydro-9-Acridinyl)Amino]Ethyl]-1h-1,2,3-Triazol-4-Yl]Hexyl]-Phenanthridinium | n/a | NAARZDJZGYBXKL-UHFFFAOYSA-O | NC1=CC2=C(C=C1)C1=CC=C(N)C=C1C(C1=CC=CC=C1)=[N+]2CCCCCCC1=CN(CCNC2=C3CCCCC3=NC3=C2C=CC=C3)N=N1 | |
24 | P22303_DB02343 | DB02343 | 3,6,9,12,15-Pentaoxaheptadecane | n/a | HYDWALOBQJFOMS-UHFFFAOYSA-N | CCOCCOCCOCCOCCOCC | |
25 | P22303_DB02404 | DB02404 | 1-Deoxy-1-Thio-Heptaethylene Glycol | n/a | ACMBXVJDKVNCGH-UHFFFAOYSA-N | OCCOCCOCCOCCOCCOCCOCCS | |
26 | P22303_DB02673 | DB02673 | (4aS,6R,8aS)-11-[8-(1,3-Dioxo-1,3-dihydro-2H-isoindol-2-yl)octyl]-6-hydroxy-3-methoxy-5,6,9,10-tetrahydro-4aH-[1]benzofuro[3a,3,2-ef][2]benzazepin-11-ium | n/a | VLGAHTYYCHWLNI-BHRZLAGCSA-N | COC1=CC=C2C=[N+](CCCCCCCCN3C(=O)C4=C(C=CC=C4)C3=O)CC[C@@]34C=C[C@H](O)C[C@@H]3OC1=C24 | |
27 | P22303_DB02825 | DB02825 | Methylphosphinate | n/a | BCDIWLCKOCHCIH-UHFFFAOYSA-M | CP([O-])=O | |
28 | P22303_DB02845 | DB02845 | Methylphosphinic Acid | n/a | BCDIWLCKOCHCIH-UHFFFAOYSA-N | CP(O)=O | |
29 | P22303_DB03005 | DB03005 | 3,8-Diamino-6-Phenyl-5-[6-[1-[2-[(1,2,3,4-Tetrahydro-9-Acridinyl)Amino]Ethyl]-1h-1,2,3-Triazol-5-Yl]Hexyl]-Phenanthridinium | n/a | ISUOMOOYAOQQPZ-UHFFFAOYSA-O | NC1=CC2=C(C=C1)C1=CC=C(N)C=C1C(C1=CC=CC=C1)=[N+]2CCCCCCC1=CN=NN1CCNC1=C2CCCCC2=NC2=C1C=CC=C2 | |
30 | P22303_DB03283 | DB03283 | beta-L-fucose | n/a | SHZGCJCMOBCMKK-KGJVWPDLSA-N | C[C@@H]1O[C@H](O)[C@@H](O)[C@H](O)[C@@H]1O | |
31 | P22303_DB03348 | DB03348 | Huperzine B | n/a | YYWGABLTRMRUIT-HWWQOWPSSA-N | [H][C@]12CCCN[C@]11CC(C)=C[C@H]2CC2=C1C=CC(=O)N2 | |
32 | P22303_DB03359 | DB03359 | M-(N,N,N-Trimethylammonio)-2,2,2-Trifluoro-1,1-Dihydroxyethylbenzene | n/a | KGVDBJQLTHWAJF-UHFFFAOYSA-N | C[N+](C)(C)C1=CC=CC(=C1)C(O)(O)C(F)(F)F | |
33 | P22303_DB03740 | DB03740 | N-acetyl-alpha-D-glucosamine | n/a | OVRNDRQMDRJTHS-PVFLNQBWSA-N | CC(=O)N[C@H]1[C@@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O | |
34 | P22303_DB03814 | DB03814 | 2-(N-morpholino)ethanesulfonic acid | n/a | SXGZJKUKBWWHRA-UHFFFAOYSA-N | OS(=O)(=O)CCN1CCOCC1 | |
35 | P22303_DB04021 | DB04021 | MF268 | n/a | UXVBAZRPAJEAHR-GASCZTMLSA-N | [H][C@]1(C)CN(CCCCCCCCNC=O)C[C@@]([H])(C)O1 | |
36 | P22303_DB04114 | DB04114 | 3-Chloro-9-Ethyl-6,7,8,9,10,11-Hexahydro-7,11-Methanocycloocta[B]Quinolin-12-Amine | n/a | QTPHSDHUHXUYFE-NWDGAFQWSA-N | [H][C@]12CC3=C(C(N)=C4C=CC(Cl)=CC4=N3)[C@]([H])(CC(CC)=C1)C2 | |
37 | P22303_DB04556 | DB04556 | NAP-226-90 | n/a | GQZXRLWUYONVCP-QMMMGPOBSA-N | C[C@H](N(C)C)C1=CC(O)=CC=C1 | |
38 | P22303_DB04614 | DB04614 | (R)-tacrine(10)-hupyridone | n/a | ROTFGKJJMRTWBD-HHHXNRCGSA-N | O=C1NC2=C(C=C1)[C@@H](CCC2)NCCCCCCCCCCNC1=C2CCCCC2=NC2=CC=CC=C12 | |
39 | P22303_DB04615 | DB04615 | (S)-tacrine(10)-hupyridone | n/a | ROTFGKJJMRTWBD-MHZLTWQESA-N | O=C1NC2=C(C=C1)[C@H](CCC2)NCCCCCCCCCCNC1=C2CCCCC2=NC2=CC=CC=C12 | |
40 | P22303_DB04616 | DB04616 | TACRINE(8)-4-AMINOQUINOLINE | n/a | IC50(nM) = 8.8 | UNVOAAWEEGAXTN-UHFFFAOYSA-N | C(CCCCNC1=C2CCCCC2=NC2=CC=CC=C12)CCCNC1=CC=NC2=CC=CC=C12 |
41 | P22303_DB04617 | DB04617 | (9S)-9-[(8-AMMONIOOCTYL)AMINO]-1,2,3,4,9,10-HEXAHYDROACRIDINIUM | n/a | LFBAUYQQFKFFCF-UHFFFAOYSA-P | [NH3+]CCCCCCCCNC1=C2CCCCC2=[NH+]C2=CC=CC=C12 | |
42 | P22303_DB04859 | DB04859 | Zanapezil | n/a | IC50(nM) = 100.0 EC50(nM) = 1140.0 | PMBLXLOXUGVTGB-UHFFFAOYSA-N | O=C(CCC1CCN(CC2=CC=CC=C2)CC1)C1=CC2=C(CCCCN2)C=C1 |
43 | P22303_DB04864 | DB04864 | Huperzine A | inhibitor | Ki(nM) = 4.6 IC50(nM) = 47.0 | ZRJBHWIHUMBLCN-YQEJDHNASA-N | [H][C@@]12CC3=C(C=CC(=O)N3)[C@@](N)(CC(C)=C1)\C2=C\C |
44 | P22303_DB04892 | DB04892 | Phenserine | n/a | IC50(nM) = 21.0 EC50(nM) = 25.0 | PBHFNBQPZCRWQP-QUCCMNQESA-N | [H][C@]12N(C)CC[C@@]1(C)C1=C(C=CC(OC(=O)NC3=CC=CC=C3)=C1)N2C |
45 | P22303_DB04924 | DB04924 | Itopride | inhibitor | QQQIECGTIMUVDS-UHFFFAOYSA-N | COC1=CC=C(C=C1OC)C(=O)NCC1=CC=C(OCCN(C)C)C=C1 | |
46 | P22303_DB06525 | DB06525 | Ganstigmine | n/a | ZOBDWFRKFSPCRB-UNMCSNQZSA-N | CCC1=C(NC(=O)OC2=CC3=C(C=C2)N(C)[C@H]2ON(C)CC[C@@]32C)C=CC=C1 | |
47 | P22303_DB07555 | DB07555 | Hydroxy(oxo)(2-{(1S)-2,2,2-trifluoro-1-[2-(trimethylarsonio)ethoxy]ethyl}phenyl)ammonium | n/a | LUSVMAVUPPIHKA-LBPRGKRZSA-N | [H][C@](OCC[As+](C)(C)C)(C1=CC=CC=C1[N+](O)=O)C(F)(F)F | |
48 | P22303_DB07701 | DB07701 | 1-BENZYL-4-[(5,6-DIMETHOXY-1-INDANON-2-YL)METHYL]PIPERIDINE | n/a | ADEBPBSSDYVVLD-HXUWFJFHSA-N | [H][C@@]1(CC2CCN(CC3=CC=CC=C3)CC2)CC2=CC(OC)=C(OC)C=C2C1=O | |
49 | P22303_DB07756 | DB07756 | 1-[3-({[(4-AMINO-5-FLUORO-2-METHYLQUINOLIN-3-YL)METHYL]THIO}METHYL)PHENYL]-2,2,2-TRIFLUOROETHANE-1,1-DIOL | n/a | GPBGHVRNVGXPNM-UHFFFAOYSA-N | CC1=C(CSCC2=CC(=CC=C2)C(O)(O)C(F)(F)F)C(N)=C2C(F)=CC=CC2=N1 | |
50 | P22303_DB07846 | DB07846 | (3,4,8b-Trimethyl-3-oxido-2,3a-dihydro-1H-pyrrolo[2,3-b]indol-3-ium-7-yl) N-(2-ethylphenyl)carbamate | n/a | MVHRCJQCKYPDRL-UHFFFAOYSA-N | CCC1=CC=CC=C1NC(=O)OC1=CC2=C(C=C1)N(C)C1C2(C)CC[N+]1(C)[O-] | |
51 | P22303_DB08167 | DB08167 | Methylthioninium | n/a | RBTBFTRPCNLSDE-UHFFFAOYSA-N | CN(C)C1=CC2=[S+]C3=CC(=CC=C3N=C2C=C1)N(C)C | |
52 | P22303_DB08357 | DB08357 | Diethylene glycol diethyl ether | n/a | RRQYJINTUHWNHW-UHFFFAOYSA-N | CCOCCOCCOCC | |
53 | P22303_DB08615 | DB08615 | 2-[4-(DIMETHYLAMINO)PHENYL]-6-HYDROXY-3-METHYL-1,3-BENZOTHIAZOL-3-IUM | n/a | NOVJJPLRUMZSDK-UHFFFAOYSA-O | CN(C)C1=CC=C(C=C1)C1=[N+](C)C2=CC=C(O)C=C2S1 | |
54 | P22303_DB08996 | DB08996 | Dimetacrine | antagonist | RYQOGSFEJBUZBX-UHFFFAOYSA-N | CN(C)CCCN1C2=CC=CC=C2C(C)(C)C2=CC=CC=C12 | |
55 | P22303_DB12816 | DB12816 | Terpinen-4-ol | inhibitor | WRYLYDPHFGVWKC-UHFFFAOYSA-N | CC(C)C1(O)CCC(C)=CC1 | |
56 | P22303_DB14006 | DB14006 | Choline salicylate | product of | UDKCHVLMFQVBAA-UHFFFAOYSA-M | C[N+](C)(C)CCO.OC1=CC=CC=C1C([O-])=O |